Showing results (281-290 of 405) with videos related to
Sort By:
Pageof 41
Stress (Amsterdam, Netherlands)|August 9, 2022
Juvenile exposure to doxorubicin alters the cardiovascular response to adult-onset psychosocial stress in miceMarianne K O Grant, Maria Razzoli, Ibrahim Y Abdelgawad, et al.Biodegradation|March 2, 2011
Biodegradation of specified risk material and characterization of actinobacterial communities in laboratory-scale compostersShanwei Xu, G Douglas Inglis, Tim Reuter, et al.European Radiology|July 23, 1999
Self-expanding metallic stents in the management of pyloric dysfunction after gastric pull-up operationsM G Cowling, P Y Goh, R C Mason, et al.The Bone & Joint Journal|March 1, 2019
What is the incidence of late detection of developmental dysplasia of the hip in England?: a 26-year national study of children diagnosed after the age of oneC Broadhurst, A M L Rhodes, P Harper, et al.British Journal of Cancer|May 1, 1992
Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parametersP J Johnson, N Dobbs, C Kalayci, et al.Plos One|January 5, 2011
Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptorMarianne K O Grant, Meredith J Noetzel, Kayla C De Lorme, et al.Skeletal Radiology|July 1, 1995
Visualisation of subchondral erosion in rat monoarticular arthritis by magnetic resonance imagingT A Carpenter, J R Everett, L D Hall, et al.Blood|December 17, 2009
Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic miceDavid Caudell, David P Harper, Rachel L Novak, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2000
A comparison of methods currently used in clinical practice to estimate familial breast cancer risksM Tischkowitz, D Wheeler, E France, et al.Journal of Hepatology|July 1, 1991
Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodolP J Johnson, C Kalayci, N Dobbs, et al.Pageof 41